FDA Investigator Marco A Solorio
Marco A Solorio has conducted inspections on 86 sites in 1 countries as of 28 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
86
Last Inspection Date:
28 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Marco A Solorio:
Adam C Hipko,
Adriana Meza,
Alexander M Kay,
Alexandra B Pitkin,
Alexis R Ajello,
Ali Hernandez,
Aliza Chalapong Asawesna,
Altino C Mckelvey,
Ana Djurdjevic,
Andrew Tadros,
Angela Shepas,
Angelica Ornelas,
Anthony E Guzman,
Arnold C Shih,
Ashley J Allen Gaines,
Benigno B Devera,
Bonnie I Needleman,
Boris L Nesbitt,
Brandon R Boone,
Breena L D'ambrogi,
Bush,
Carla J Lundi,
Carla M Fernandez Borges,
Cathleen A Carr Sharpe,
Cathryn M Groehnert,
Celena Ngo,
Christina D Mello,
Comyar Shoghi,
Daniel C Geffin,
Daniel J Simonsen,
Darrin E Davis,
David Serrano,
David Y Hernandez,
Davis,
Deborah A Greco,
Deborah W Hsu,
Debra J Fracassa,
Denise Connelly,
Dennis N Hoang,
Desiree C Iya,
Dyana K Stone,
Eileen T Dupont,
Elizabeth M Dahl,
Erica Fernandez,
Erik D Sandvig,
Fe Q Reyes,
Francisco,
Gene Matienzo,
Geraldine M Peregrin,
Gordon Chu,
Hagstrom,
Hai T Truong,
Hanna S Louvau,
Henry E Carrillo,
Herminio C Francisco,
Homero W Aguilar,
Jacey Roy,
James R Fleckenstein,
Jane G Choi,
Janett Avila,
Jeannie Pradyanata,
Jessica L Andrade,
Jinnie Kokiatkulkij,
John A Daubenspeck,
John A Liu,
John C Sedwick,
John C Su,
John Cook,
John R Myung,
Jolanna A Norton,
Jose O Caraballo Rivera,
Joseph C Francisco,
Joseph H Lam,
Judy C Nepsa,
Kai Wang,
Karla J Gibler,
Katherine P Tran,
Kazuhiro Okumura,
Keeshunna D Daniels,
Kelvin X Sanders,
Kevin Lee,
Kham Phommachanh,
Kimberly M Lichter,
Lilly O Barton,
Lin Liu,
Lisa M Schultz,
Liza L Quiles,
Lourdes M Countee,
Loydis Laureano,
Makia P Dove,
Marcus D Fairconnetue,
Mark C Saale,
Mary C Wall,
Matthew C Kristof,
Michael D Garcia,
Michael J Chan,
Miyo M Saito,
Nianna C Burns,
Nicholas J Lahey,
Ounchith J Phabmixay,
Pamela Y Lee,
Patrick R Dimapindan,
Phillip L Toy,
Rachel E Hauser,
Raymond W Brullo,
Richard G Fochesato,
Richard W Tubb,
Rochelle A Rolnik,
Ryan J Borges,
Sabrina J Dethloff,
Sara Jdent Acosta,
Sarah R Barker,
Savannah E Samp,
Susanna N Choi,
Sylvia A Thomas,
Takiyah S Gilmore Embery,
Tamara L Alexander,
Tammy Vasquez Hancock,
Tanya E Malais,
Terrance P Nguyen,
Thao T Kwan,
Theresa Kirkham (NMI),
Tomanik'e C Banks,
Tony J Wu,
Victoria C Yang,
William J Leonard,
Yen Tso Kuo,
Yvette Mlacour Davis,
Yvonne T Lacour,
Zenja D Woodley
Marco A Solorio's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2011 | FDA 483 | American Copak Corporation - Form 483, 2011-07-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more